Abstract-Polymorphism of the dopamine receptor type-2 (D 2 ) gene is associated with essential hypertension. To assess whether D 2 receptors participate in regulation of blood pressure (BP), we studied mice in which the D 2 receptor was disrupted. In anesthetized mice, systolic and diastolic BPs (in millimeters of mercury) were higher in D 2 homozygous and heterozygous mutant mice than in D 2 ϩ/ϩ littermates. BP after ␣-adrenergic blockade decreased to a greater extent in D 2 Ϫ/Ϫ mice than in D 2 ϩ/ϩ mice. Epinephrine excretion was greater in D 2 Ϫ/Ϫ mice than in D 2 ϩ/ϩ mice, and acute adrenalectomy decreased BP to a similar level in D Disruption of D 3 receptors in mice produces hypertension mediated, at least in part, by activation of the renin-angiotensin system. 7 The D 2 receptor could be involved in D 2 -likemediated hypertension because it is the major D 2 -like dopamine receptor. 3,8 -11 Moreover, BP decreased when a segment of chromosome 8 that contained the D 2 receptor gene was transferred from a normotensive Brown Norway rat to a spontaneously hypertensive rat background. 12 Several variants of the human D 2 dopamine receptor have been reported. 13 Abnormalities of D 2 receptor genes could play a role in the pathogenesis of essential hypertension, because the association of a D 2 dopamine receptor polymorphism with obesity and hypertension has been reported. 14 To determine whether D 2 receptors play a role in the regulation of BP, we measured arterial pressure in congenic B6 mice mutants for the D 2 receptor. 8,9 Because D 2 -like receptors have been shown to interact with vasopressor systems, 1, 6, 15, 16 interactions between D 2 receptors and other vasopressor systems were also studied.
D
opamine can regulate cardiovascular function by its actions on central cardiovascular centers, the pituitary and adrenal glands, kidney, cardiac and vascular smooth muscle, and the sympathetic nervous system. 1,2 Effects of dopamine are mediated by dopamine receptor type-1 and type-2 (D 1 -and D 2 )-like receptors that belong to the G protein-coupled receptor family. [1] [2] [3] Both D 1 -and D 2 -like receptors have been shown to regulate arterial blood pressure (BP). 1, 2 Genetic hypertension in rodents and humans has been shown to be associated with decreased activity of D 1 -like receptors in the kidney and central nervous system. 1, 2 Decreased D 2 -like dopaminergic activity in the central nervous system has been reported in essential hypertension. 1, 4 Several studies in animal models of genetic hypertension also support the notion of altered central D 2 -like dopaminergic activity in hypertension. 5, 6 However, 3 D 2 -like dopamine receptors, D 2 , D 3 , and D 4 , exist, and which of the 3 cloned D 2 -like receptors participate in the D 2 -like regulation of BP is unclear. [1] [2] [3] Disruption of D 3 receptors in mice produces hypertension mediated, at least in part, by activation of the renin-angiotensin system. 7 The D 2 receptor could be involved in D 2 -likemediated hypertension because it is the major D 2 -like dopamine receptor. 3,8 -11 Moreover, BP decreased when a segment of chromosome 8 that contained the D 2 receptor gene was transferred from a normotensive Brown Norway rat to a spontaneously hypertensive rat background. 12 Several variants of the human D 2 dopamine receptor have been reported. 13 Abnormalities of D 2 receptor genes could play a role in the pathogenesis of essential hypertension, because the association of a D 2 dopamine receptor polymorphism with obesity and hypertension has been reported. 14 To determine whether D 2 receptors play a role in the regulation of BP, we measured arterial pressure in congenic B6 mice mutants for the D 2 receptor. 8, 9 Because D 2 -like receptors have been shown to interact with vasopressor systems, 1, 6, 15, 16 interactions between D 2 receptors and other vasopressor systems were also studied.
Methods

D 2 Receptor-Deficient Mice
tor allele was backcrossed to wild-type C57BL/6J for 5 generations and genotyped. 8, 9 These mice acquired normal basic motor skills without tremor, ataxia, or abnormal stance or posture but had decreased initiation of movement. 8 All studies were approved by the Georgetown University Animal Care and Use Committee.
BP and Renal Function Studies
Mice were anesthetized with pentobarbital 50 mg/kg IP, placed on a heated board to maintain body temperature at 37°C, and tracheotomized. 7 Mice were euthanatized (pentobarbital 100 mg/kg) at the conclusion of the study.
Effect of Agonists and Antagonists on BP
Because preliminary studies indicated that arterial pressures were higher in D 2 Ϫ/Ϫ than D 2 ϩ/ϩ mice, we determined the mechanism of increase in BP by intravenous infusion of antagonists of pressor agents. After a 60-minute stabilization period, drugs were infused in random order: 20 and ET-1 0.1 to 1.3 pmol/kg were also studied.
Adrenalectomy
Effect of adrenalectomy on BP was also studied in some mice. After a midline abdominal incision, adrenal gland was separated from kidney, ligated, crushed with forceps, and excised. BP readings were obtained after a 20-minute stabilization period.
Immunoblotting Studies
Because blockade of ET(B) receptors normalized BP in D 2 Ϫ/Ϫ mice (see Results), we immunoblotted for ET(B) receptors (Maine Biotechnology Services, Inc) of liver; ET-1 has been reported to induce constriction of hepatic circulation through both ET(A) and ET(B) receptors. 22 Renal D 2 receptors were also immunoblotted with purified rat striatum as positive control (Chemicon). 7 Negative controls included rabbit IgG instead of primary antibody, secondary antibody alone, and D 2 antibody preadsorbed with immunizing peptide. D 2 -specific bands (49 and 98 kDa) and ET(B)-specific bands (49 kDa) were visualized by use of enhanced chemiluminescence Western blotting detection kit (Amersham Biotech).
Determination of Na
؉ ,K ؉ -ATPase Activity Na ϩ ,K ϩ -ATPase activity is as described previously. 23 
Determination of Catecholamines
Kidneys were homogenized with 0.1 mol/L HClO 4 and centrifuged at 6000g for 20 minutes at 4°C. Supernatant, urine, and plasma were flash-frozen and stored at Ϫ70°C until assay. 24 
Determination of Plasma EndothelinImmunoreactive Levels
Fifty microliters of plasma was diluted with 1% TCA and centrifuged at 14 000 rpm for 20 minutes at 4°C. Supernatants were loaded into separation columns preequilibrated with 100% acetonitrile and washed with 1% TCA. Peptides were eluted (60% acetonitrile in 1% TCA), lyophilized, and quantified by ELISA (Peninsula).
Statistical Analyses
Data (meanϮSE) were analyzed by 1-way or repeated ANOVA or t test as indicated.
Results
General Characteristics
D 2 ϩ/Ϫ mice were heavier than either D 2 ϩ/ϩ or D 2 Ϫ/Ϫ mice (Table 1) . Heart and kidney weights as a percentage of body weight were similar among the groups. Heart rate was significantly elevated in D 2 Ϫ/Ϫ mice versus D 2 ϩ/ϩ mice. Furthermore, systolic, diastolic, and mean arterial pressures were also higher in mice heterozygous and homozygous for mutated D 2 receptor allele compared with wild-type mice. D 2 receptors (47 and 98 kDa) were detected in rat striatal tissues (positive control) but not in renal cortical or medullary tissue from rats or from D 2 Ϫ/Ϫ or D 2 ϩ/ϩ mice (data not shown).
Effect of Saline Loading
Basal urine flow rate and sodium excretion were greater in D 2 Ϫ/Ϫ mice than in D 2 ϩ/ϩ mice ( Figure 1 ). Saline loading increased urine flow and absolute ( Figure 1 ) and fractional sodium (data not shown) excretion in all the mice. However, the increase was greater in D 2 Ϫ/Ϫ mice than in D 2 ϩ/ϩ mice. Glomerular filtration rate was similar in D 2 Ϫ/Ϫ and D 2 ϩ/ϩ mice and was not affected by saline loading. Arterial pressures were not affected by the acute saline load (data not shown). 
Effect of Receptor Ligands on BPs
Effect of ␣-Adrenergic Antagonist
Phentolamine, an ␣-adrenergic antagonist, markedly decreased BP in D 2 mutant and wild-type mice. The magnitude of the decrease in BP was greater in D 2 Ϫ/Ϫ than D 2 ϩ/ϩ mice ( Figure 2B ), ultimately resulting in similar BPs at the nadir of the phentolamine effect. Moreover, acute adrenalectomy decreased BP in D 2 Ϫ/Ϫ (mean BP in mm Hg before adrenalectomy, 101Ϯ5; after adrenalectomy, 52Ϯ14; nϭ3), D 2 ϩ/Ϫ (mean BP before adrenalectomy, 101Ϯ2; after adrenalectomy, 61Ϯ4; nϭ4) and D 2 ϩ/ϩ (mean BP before adrenalectomy, 82Ϯ2; after adrenalectomy, 47Ϯ8; nϭ2) mice, such that BPs were no longer different among groups. Figure 3A) . RES-701᎑1 increased BP to a greater extent in D 2 Ϫ/Ϫ than D 2 ϩ/ϩ mice.
Effects of ET(A) and ET(B) Antagonists
Effects of ET-1 and ET(B) Agonist
Because ET(B1) and ET(B2) effects were increased in D 2 mutant mice, we determined the effect of ET-1 on BP. ET-1 0.1 to 1.3 nmol/kg tended to increase BP to a greater extent in D 2 ϩ/ϩ than D 2 Ϫ/Ϫ mice (maximum increase, 23Ϯ5% and 17Ϯ5%, respectively; nϭ3 to 6 per group), but significant differences were not found. ET(B) agonist sarafotoxin S6c also tended to increase BP to a greater extent in D 2 ϩ/ϩ than D 2 Ϫ/Ϫ mice (maximum increase, 33Ϯ10% and 30Ϯ4%, respectively) but reached significance only at 0.3 nmol/kg (D 2 ϩ/ϩ, 21Ϯ5% versus D 2 Ϫ/Ϫ, 10Ϯ1%; PϽ0.05 by t test; nϭ3 to 6 per group).
Endothelin Receptor Protein and Endothelin-Like Immunoreactive Levels
Immunoreactive ET(B) receptors were 3-fold greater in D 2 Ϫ/Ϫ than D 2 ϩ/ϩ mice ( Figure 3B ). Plasma immunoreactive endothelin levels were not different between D 2 ϩ/ϩ (1.20Ϯ0.42 ng/mL) and D 2 Ϫ/Ϫ (0.75Ϯ0.24 ng/mL) mice, although a trend occurred toward lower values in D 2 Ϫ/Ϫ mice. These values are 5 to 100 times greater than that previously reported in mice, 25 because the antibody used cross-reacts with ET-1, ET-2, and big endothelin (Peninsula).
Catechol Levels
Renal catechol levels were similar in D 2 ϩ/ϩ and D 2 Ϫ/Ϫ mice (data not shown). Urinary catechols were also similar except for urinary epinephrine. Epinephrine excretion rates were generally higher before (baseline, urine period 1), during (urine period 2), and after saline loading (urine periods 3 through 5) in D 2 Ϫ/Ϫ versus D 2 ϩ/ϩ mice ( Table 2) . Urinary dopamine and norepinephrine tended to increase with saline 
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loading in D 2 ϩ/ϩ mice and reached statistical significance in D 2 Ϫ/Ϫ mice; the percentage increases in urinary dopamine (85%) and urinary norepinephrine (108%) with saline loading (compared with baseline) were similar in D 2 ϩ/ϩ and D 2 Ϫ/Ϫ mice. These changes were associated with increased urine flow but not with glomerular filtration rate (data not shown).
Discussion
Our data suggest that disruption of the D 2 dopamine receptor, The hypertensive phenotype was unlikely to be caused by genetic heterogeneity, because mice have been inbred to the fifth generation. 7 Both ␣ 2 -adrenergic and D 2 dopamine receptors are involved in prejunctional inhibition of catecholamine release. 3, 15, 16 ␣ 2A -Adrenergic receptor has been shown to inhibit sympathetic outflow, and disruption of this receptor in mice increased BP. 26 Stimulation of prejunctional D 2 -like receptors also inhibited sympathetic outflow. 3, 15, 16 In contrast, stimulation of postsynaptic D 2 -like receptors in the nervous system and arterial vessels increased vascular resistance or BP. 6, 27 The pressor effect of intravenously administered D 2 -like drugs was transient, whereas the peripheral vasodilator effect, presumably caused by actions at prejunctional D 2 -like receptors, was persistent. 16 The decrease in BP after ␣-adrenergic blockade in D 2 Ϫ/Ϫ mice suggests that sympathetic activity may have increased as a result of withdrawal of D 2 receptor actions at prejunctional receptors. Thus, acute adrenalectomy decreased BP such that BPs were no longer different among groups. Moreover, urinary epinephrine levels were elevated in D 2 Ϫ/Ϫ compared with D 2 ϩ/ϩ mice; D 2 receptors in the adrenal medulla inhibit epinephrine release. 27 Similar renal and urinary norepinephrine levels in D 2 ϩ/ϩ and D 2 Ϫ/Ϫ mice may be explained by observations of catecholamine metabolism in striatum of D 2 Ϫ/Ϫ mice. Monoamine levels in striatum were similar in D 2 Ϫ/Ϫ and D 2 ϩ/ϩ mice, although dopamine metabolites were increased. 9, 10 An unexpected finding in these studies was the ability of BQ-788, an ET(B1)/ET(B2) antagonist, to decrease and normalize BP, whereas ET(B1) antagonist RES-701᎑1 increased BP in D 2 Ϫ/Ϫ mice without affecting BP in D 2 ϩ/ϩ mice. ET(A) antagonist BQ-610 had no effect on BP in either D 2 Ϫ/Ϫ or D 2 ϩ/ϩ mice. The endothelins (ET-1, ET-2, and ET-3), which are generally vasoconstrictors, exert their actions by means of ET(A) and ET(B) receptors. 18 -20,25,28 However, endothelins can also mediate vasodilation. 19, 20, 25, 28 On the basis of pharmacological evidence, 2 types of ET(B) receptors have been postulated: ET(B1), which is a relaxant, and ET(B2) which is a constrictor. 19, 20, 25, 28 In ET(B) knockout mice, both vasodilatory and vasoconstrictor effects of ET(B) receptors were eliminated, which suggests that ET(B1) and ET(B2) receptors are the same receptor. 29 The difference in their actions may be related to the sites at which these receptors are expressed. For example, ET(B) (ET[B1]) receptors expressed in endothelial cells are vasodilatory because of their linkage to nitric oxide and prostaglandins 25, 29 ; the ability of prejunctional ET(B) (ET[B1]) receptors to inhibit catecholamine release may also contribute to decreasing vascular resistance. 30 Elimination of the ET(B1)-mediated stimulation of endothelial prostacyclin production has been suggested to be the cause of hypertension in ET(B)-deficient mice. 25 If an ET(B1)-mediated increase in endothelial or prostacyclin production does not occur, however, then the vasoconstrictor effect of ET(B2) would become unopposed, 25, 28, 29 which would result in hypertension. The anticipated inhibitory effect of ET(B1) on catecholamine release 30 32 The site of interaction between D 2 dopamine receptors and ET(B) receptors was not determined in the present studies. Dopamine, dopamine receptors, endothelin, and ET(B) receptors have been found in brain and spinal regions known to control cardiovascular function. 33 Depletion of dopamine production in the striatum has been reported to decrease ET receptors. 33 Decreased clearance of dopamine in D 2 Ϫ/Ϫ mice 9,10 may have led to upregulation of vasoconstricting ET(B2) receptors in the tunica media of resistance vessels. Another explanation may be that the absence of inhibitory effect of D 2 receptors on ET(B1) receptors in adrenal medulla of D 2 Ϫ/Ϫ mice could have led to the increase in circulating epinephrine. 30, 34 We have reported that disruption of the D 3 receptor in mice leads to development of renin-dependent hypertension and decreased ability to excrete sodium load. 7 In the present studies, D 2 Ϫ/Ϫ mice not only had a greater basal urine flow rate and sodium excretion than D 2 ϩ/ϩ mice but also responded to saline loading with greater natriuresis and diuresis than the D 2 ϩ/ϩ mice. Increased sodium excretion in the DϪ/Ϫ mice was associated with lower Na ϩ ,K ϩ -ATPase activity, the cause of which remains to be determined. However, ET(B) receptors have been reported to decrease chloride transport at the thick ascending limb of Henle. 35 Pressure natriuresis also may have contributed to increased sodium excretion in the D 2 Ϫ/Ϫ mice.
In summary, on the basis of our examination of D 2 receptor-deficient mice, we conclude that D 2 dopamine receptors expressed on sympathetic neurons normally act to inhibit sympathetic outflow from the nervous system. 15, 16 When Ն50% of the D 2 receptor population is depleted, concomitant increases occur in sympathetic outflow and expression of ET(B) receptors in several tissues, including liver and, presumably, vascular smooth muscle cells as well. The absence of inhibitory tone on sympathetic outflow mediated by the D 2 dopamine receptor coupled with increased ET(B) activity may predispose the animal to hypertension.
